T1	PROC 46 89	Evaluación de la eficacia y de la seguridad
T2	DISO 109 130	enfermedad de Cushing
#1	AnnotatorNotes T2	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T3	PROC 153 211	Estudio fase III, multicéntrico, aleatorizado, doble ciego
T4	PROC 265 287	controlado con placebo
#2	AnnotatorNotes T4	C1706408; Placebo Control; Research Activity
T5	PROC 294 328	evaluar la seguridad y la eficacia
#3	AnnotatorNotes T5	C0511730; Identify product efficacy and safety issues; Health Care Activity
T6	DISO 362 383	enfermedad de Cushing
#4	AnnotatorNotes T6	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T7	DISO 407 428	enfermedad de Cushing
#5	AnnotatorNotes T7	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T8	DISO 507 509	EC
#6	AnnotatorNotes T8	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T9	PROC 695 698	SRS
T10	ANAT 602 612	pituitaria
#7	AnnotatorNotes T10	C0599332; Olfactory Epithelium; Tissue
T11	PROC 666 693	radiocirugía estereotáctica
#8	AnnotatorNotes T11	C3846112; Radiosurgery, Stereotactic; Therapeutic or Preventive Procedure
T12	PROC 871 892	terapia farmacológica
#9	AnnotatorNotes T12	C0013216; Pharmacotherapy; Therapeutic or Preventive Procedure
T13	DISO 908 910	EC
#10	AnnotatorNotes T13	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T14	PROC 970 979	protocolo
#11	AnnotatorNotes T14	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T15	CHEM 1039 1063	fármaco en investigación
#12	AnnotatorNotes T15	C0013230; Investigational New Drugs; Pharmacologic Substance
T16	DISO 1108 1131	síndrome pseudo-Cushing
#13	AnnotatorNotes T16	C0342445; Pseudo-Cushing's syndrome; Disease or Syndrome
T17	ANAT 1168 1184	sistema orgánico
#14	AnnotatorNotes T17	C0460002; body system; Body System
T18	DISO 1244 1263	Torsades de Pointes
#15	AnnotatorNotes T18	C0040479; Torsades de Pointes; Disease or Syndrome
T19	PROC 1455 1478	métodos anticonceptivos
#16	AnnotatorNotes T19	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T20	CHEM 332 344	osilodrostat
#17	AnnotatorNotes T20	C4330903; osilodrostat; Organic Chemical · Pharmacologic Substance
T21	PROC 590 612	irradiación pituitaria
T22	DISO 1148 1158	malignidad
#18	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process
T23	CHEM 93 105	osilodrostat
#19	AnnotatorNotes T23	C4330903; osilodrostat; Organic Chemical · Pharmacologic Substance
T24	PROC 714 723	radiación
#20	AnnotatorNotes T24	C1522449; Therapeutic radiology procedure; Therapeutic or Preventive Procedure
T25	Date 13 17	2014
T26	Duration 216 226	48 semanas
T27	Duration 254 264	12 semanas
T28	LIVB 348 357	pacientes
#21	AnnotatorNotes T28	C0030705; Patients; Patient or Disabled Group
T29	LIVB 455 482	Pacientes varones o mujeres
#22	AnnotatorNotes T29	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T32	Age 483 506	mayores de 18 - 75 años
T33	LIVB 560 569	pacientes
#23	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	Duration 641 660	por lo menos 2 años
T35	Duration 702 708	3 años
T36	LIVB 782 794	investigador
#24	AnnotatorNotes T36	C0035173; Research Personnel; Professional or Occupational Group
T37	Date 893 899	actual
T39	LIVB 1094 1103	Pacientes
#25	AnnotatorNotes T39	C0030705; Patients; Patient or Disabled Group
T40	LIVB 1185 1194	Pacientes
#26	AnnotatorNotes T40	C0030705; Patients; Patient or Disabled Group
T41	Spec_cue 1211 1217	riesgo
T42	LIVB 1264 1311	Pacientes embarazadas o en periodo de lactancia
#27	AnnotatorNotes T42	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T43	LIVB 1312 1340	Mujeres físicamente fértiles
#28	AnnotatorNotes T43	C4324275; Woman of childbearing potential; Population Group
T45	LIVB 1367 1374	mujeres
#29	AnnotatorNotes T45	C0043210; Woman; Population Group
T47	PHYS 1274 1285	embarazadas
#30	AnnotatorNotes T47	C0032961; Pregnancy; Organism Function
T31	PHYS 1302 1311	lactancia
#32	AnnotatorNotes T31	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T49	PHYS 801 809	entender
#33	AnnotatorNotes T49	C0162340; Comprehension; Mental Process
T50	PHYS 758 769	comunicarse
#34	AnnotatorNotes T50	C2911692; Response (communication); Mental Process (?)
A1	Assertion T18 Speculated
A2	Status T21 History_of
A4	Status T11 History_of
A5	Status T9 History_of
A6	Status T24 History_of
A7	Status T22 History_of
#35	AnnotatorNotes T1	C0511730; Identify product efficacy and safety issues; Health Care Activity
#36	AnnotatorNotes T3	C0282461; Phase 3 Clinical Trials; Research Activity + C1096776; Multicenter Study; Research Activity + C0034656; Randomization; Research Activity + C0013072; Double-Blind Method; Research Activity
#37	AnnotatorNotes T9	C3846112; Radiosurgery, Stereotactic; Therapeutic or Preventive Procedure
#38	AnnotatorNotes T37	C0521116; Current (present time); Temporal Concept 
T30	DISO 1221 1241	prolongación del QTc
A3	Assertion T30 Speculated
R1	Speculation Arg1:T41 Arg2:T30	
R2	Speculation Arg1:T41 Arg2:T18	
#39	AnnotatorNotes T30	C1560305; Prolonged QTc interval; Pathologic Function
R3	Has_Duration_or_Interval Arg1:T3 Arg2:T26	
R4	Has_Duration_or_Interval Arg1:T4 Arg2:T27	
R5	Experiences Arg1:T28 Arg2:T20	
R6	Experiences Arg1:T28 Arg2:T6	
R8	Has_Age Arg1:T29 Arg2:T32	
T38	Quantifier_or_Qualifier 529 540	persistente
#40	AnnotatorNotes T38	C0205322; Persistent; Temporal Concept
R9	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T38	
T44	Quantifier_or_Qualifier 543 554	concurrente
#41	AnnotatorNotes T44	C0205420; Concurrent; Temporal Concept
R10	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T44	
R11	Experiences Arg1:T33 Arg2:T21	
R12	Location_of Arg1:T10 Arg2:T21	
R13	Has_Duration_or_Interval Arg1:T21 Arg2:T34	
R14	Experiences Arg1:T33 Arg2:T11	
R15	Experiences Arg1:T33 Arg2:T9	
R16	Experiences Arg1:T33 Arg2:T24	
R17	Before Arg1:T11 Arg2:T34	
R18	Before Arg1:T9 Arg2:T34	
R19	Has_Duration_or_Interval Arg1:T21 Arg2:T35	
R20	Before Arg1:T24 Arg2:T35	
T46	Observation 812 838	cumplir con los requisitos
#42	AnnotatorNotes T46	C0582783; Ability to comply with treatment; Finding (?)
T51	CONC 851 857	Lavado
#43	AnnotatorNotes T51	C1710661; Wasout Period; Temporal Concept
R21	Before Arg1:T12 Arg2:T51	
R22	Overlap Arg1:T12 Arg2:T37	
T52	Observation 749 754	Capaz
#44	AnnotatorNotes T52	C1299581; Able (finding); Finding (?)
R23	Overlap Arg1:T52 Arg2:T50	
R24	Overlap Arg1:T52 Arg2:T46	
R25	Overlap Arg1:T52 Arg2:T49	
T53	CONC 1084 1093	inclusión
#45	AnnotatorNotes T53	C1512693; Inclusion; Qualitative Concept
R26	Overlap Arg1:T15 Arg2:T53	
T54	CONC 235 250	periodo inicial
#46	AnnotatorNotes T54	C0205265; Initially; Temporal Concept
R27	Has_Duration_or_Interval Arg1:T54 Arg2:T27	
R28	Overlap Arg1:T4 Arg2:T54	
R29	Experiences Arg1:T39 Arg2:T16	
R30	Location_of Arg1:T17 Arg2:T22	
R31	Experiences Arg1:T40 Arg2:T30	
R32	Experiences Arg1:T40 Arg2:T18	
T55	Observation 1199 1217	factores de riesgo
R33	Experiences Arg1:T40 Arg2:T55	
R34	Before Arg1:T55 Arg2:T30	
R35	Before Arg1:T55 Arg2:T18	
R36	Experiences Arg1:T42 Arg2:T47	
R37	Experiences Arg1:T42 Arg2:T31	
T56	PHYS 1392 1423	capaces de quedarse embarazadas
#47	AnnotatorNotes T56	C3831118; Childbearing Potential; Clinical Attribute
R39	Experiences Arg1:T45 Arg2:T56	
R40	Experiences Arg1:T43 Arg2:T56	
R41	Experiences Arg1:T43 Arg2:T19	
R42	Experiences Arg1:T45 Arg2:T19	
R43	Overlap Arg1:T13 Arg2:T37	
T48	Quantifier_or_Qualifier 1479 1497	altamente eficaces
R38	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T48	
#31	AnnotatorNotes T55	C0035648; risk factors; Finding
T58	Quantifier_or_Qualifier 736 747	fraccionada
A9	Status T58 History_of
R44	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T58	
#48	AnnotatorNotes T21	C0032018; Pituitary Irradiation; Therapeutic or Preventive Procedure
A8	Experiencer T28 Patient
A10	Experiencer T29 Patient
A11	Experiencer T33 Patient
A12	Experiencer T36 Other
A13	Experiencer T39 Patient
A14	Experiencer T40 Patient
A15	Experiencer T42 Patient
A16	Experiencer T45 Patient
A17	Experiencer T43 Patient
A18	Assertion T19 Hypothetical
A19	Assertion T48 Hypothetical
